Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
David J. Kerr, Thomas E. Wheldon, Sharyn Hydns & Stanley B. Kaye. (1988) Cytotoxic drug penetration studies in multicellular tumour spheroids. Xenobiotica 18:6, pages 641-648.
Read now
Read now
Mads Dalmark & Else K. Hoffmann. (1983) Doxorubicin (Adriamycin) transport in Ehrlich ascites tumour cells: Comparison with transport in human red blood cells. Scandinavian Journal of Clinical and Laboratory Investigation 43:3, pages 241-248.
Read now
Read now
Articles from other publishers (37)
Emelie Ahnfelt, Oliver Degerstedt, Elsa Lilienberg, Erik Sjögren, Per Hansson & Hans Lennernäs. (2019) Lipiodol-based emulsions used for transarterial chemoembolization and drug delivery: Effects of composition on stability and product quality. Journal of Drug Delivery Science and Technology 53, pages 101143.
Crossref
Crossref
Chen‐Guang Liu, Ranjith Kumar Kankala, Hong‐Yue Liao, Ai‐Zheng Chen & Shi‐Bin Wang. (2019) Engineered pH‐responsive hydrazone‐carboxylate complexes‐encapsulated 2D matrices for cathepsin‐mediated apoptosis in cancer. Journal of Biomedical Materials Research Part A 107:6, pages 1184-1194.
Crossref
Crossref
O. P. Gnatyuk, G. I. Dovbeshko, A. Yershov, S. O. Karakhim, O. Ilchenko & O. Yu. Posudievsky. (2018) 2D-BN nanoparticles as a spectroscopic marker and drug delivery system with protection properties. RSC Advances 8:53, pages 30404-30411.
Crossref
Crossref
Karolina Matyjaszczyk, Marta Kolonko, Anna Gonciarz-Dytman, Irena Oszczapowicz, Małgorzata Łukawska, Wojciech Jawień, Stefan Chlopicki & Maria Walczak. (2017) Effects of structural modification of the daunosamine moiety of anthracycline antibiotics on pKa values determined by capillary zone electrophoresis. Journal of Chromatography B 1060, pages 44-52.
Crossref
Crossref
Juan Wang, Zhuping Yin, Xiang Xue, Subhas Kundu, Xiumei Mo & Shenzhou Lu. (2016) Natural Non-Mulberry Silk Nanoparticles for Potential-Controlled Drug Release. International Journal of Molecular Sciences 17:12, pages 2012.
Crossref
Crossref
Emelie Ahnfelt, Erik Sjögren, Per Hansson & Hans Lennernäs. (2016) In Vitro Release Mechanisms of Doxorubicin From a Clinical Bead Drug-Delivery System. Journal of Pharmaceutical Sciences 105:11, pages 3387-3398.
Crossref
Crossref
Eva Csuhai, Sogol Kangarlou, Tian-Xiang Xiang, Andrei Ponta, Paul Bummer, Duhyung Choi & Bradley D. Anderson. (2015) Determination of Key Parameters for a Mechanism-Based Model to Predict Doxorubicin Release from Actively Loaded Liposomes. Journal of Pharmaceutical Sciences 104:3, pages 1087-1098.
Crossref
Crossref
Suvi K. Soininen, Pauliina Lehtolainen-Dalkilic, Tanja Karppinen, Tiina Puustinen, Galina Dragneva, Minna U. Kaikkonen, Marjo Jauhiainen, Brigitte Allart, David L. Selwood, Thomas Wirth, Hanna P. Lesch, Ann-Marie Määttä, Jukka Mönkkönen, Seppo Ylä-Herttuala & Marika Ruponen. (2012) Targeted delivery via avidin fusion protein: Intracellular fate of biotinylated doxorubicin derivative and cellular uptake kinetics and biodistribution of biotinylated liposomes. European Journal of Pharmaceutical Sciences 47:5, pages 848-856.
Crossref
Crossref
Emily J. Danoff, Xiang Wang, Shih-Huang Tung, Nikolai A. Sinkov, Alice M. Kemme, Srinivasa R. Raghavan & Douglas S. English. (2007) Surfactant Vesicles for High-Efficiency Capture and Separation of Charged Organic Solutes. Langmuir 23:17, pages 8965-8971.
Crossref
Crossref
Katsuhito Nagai, Kazuki Nagasawa, Atsushi Ishimoto & Sadaki Fujimoto. (2003) Pirarubicin is taken up by a uridine-transportable sodium-dependent concentrative nucleoside transporter in Ehrlich ascites carcinoma cells. Cancer Chemotherapy and Pharmacology 51:6, pages 512-518.
Crossref
Crossref
Eugene A. Konorev, Hao Zhang, Joy Joseph, M. Claire Kennedy & B. Kalyanaraman. (2000) Bicarbonate exacerbates oxidative injury induced by antitumor antibiotic doxorubicin in cardiomyocytes. American Journal of Physiology-Heart and Circulatory Physiology 279:5, pages H2424-H2430.
Crossref
Crossref
Natarajan Raghunand, Raul Martı́nez–Zaguilán, Stephen H Wright & Robert J Gillies. (1999) pH and drug resistance. II. turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs. Biochemical Pharmacology 57:9, pages 1047-1058.
Crossref
Crossref
Sanford M Simon. (1999) Role of organelle pH in tumor cell biology and drug resistance. Drug Discovery Today 4:1, pages 32-38.
Crossref
Crossref
Gera D. Eytan & Philip W. Kuchel. 1999.
175
250
.
Abbas Pezeshk, Jerzy Wojas & Witold K. Subczynski. (1998) Partitioning and structural effects of the antitumor drug daunomycin on model membranes. Life Sciences 63:21, pages 1863-1870.
Crossref
Crossref
BØrge Thing Mortensen, Peter Østrup Jensen, Niels Helledie, Per Ole Iversen, Elisabeth RalfkiÆR, JØrgen Knud Larsen & Mads Thorup Madsen. (2001) Changing bone marrow micro‐environment during development of acute myeloid leukaemia in rats. British Journal of Haematology 102:2, pages 458-464.
Crossref
Crossref
Frédéric Frézard & Arlette Garnier-Suillerot. (1998) Permeability of lipid bilayer to anthracycline derivatives. Role of the bilayer composition and of the temperature. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1389:1, pages 13-22.
Crossref
Crossref
J.E. Wijker, P.R. Jensen, J.L. Snoep, A. Vaz Gomes, M. Guiral, A.P.M. Jongsma, A. de Waal, S. Hoving, S. van Dooren, C.C. van der Weijden, M. van Workum, W.C. van Heeswijk, O. Molenaar, P. Wielinga, P. Richard, J. Diderich, B.M. Bakker, B. Teusink, M. Hemker, J.M. Rohwer, A.A. van der Gugten, B.N. Kholodenko & H.V. Westerhoff. (1995) Energy, control and DNA structure in the living cell. Biophysical Chemistry 55:1-2, pages 153-165.
Crossref
Crossref
Per Ole Iversen, Borge Thing-Mortensen, Gunnar Nicolaysen & Haakon Breien Benestad. (1993) Decreased blood flow to rat bone marrow, bone, spleen, and liver in acute leukemia. Leukemia Research 17:8, pages 663-668.
Crossref
Crossref
Jolanta Tarasiuk, Jean Foucrier & Arlette Garnier-Suillerot. (1993) Cell cycle dependent uptake and release of anthracycline by drug-resistant and drug-sensitive human leukaemic K562 cells. Biochemical Pharmacology 45:9, pages 1801-1808.
Crossref
Crossref
Ellen C. SPOELSTRA, Hans V. WESTERHOFF, Henk DEKKER & Jan LANKELMA. (2005) Kinetics of daunorubicin transport by P‐glycoprotein of intact cancer cells. European Journal of Biochemistry 207:2, pages 567-579.
Crossref
Crossref
C.A. Slapak, J.M. Lecerf, J.C. Daniel & S.B. Levy. (1992) Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts.. Journal of Biological Chemistry 267:15, pages 10638-10644.
Crossref
Crossref
Abbas Pezeshk, Vida Pezeshk, Jerzy Wojas, Witold K. Subczynski & Witold K. Subczynski. (1992) Partitional and motional properties of a spin-labeled daunomycin in lipid bilayers. An ESR study. Journal of Inorganic Biochemistry 46:2, pages 67-76.
Crossref
Crossref
Christopher F. Higgins & Michael M. Gottesman. (1992) Is the multidrug transporter a flippase?. Trends in Biochemical Sciences 17:1, pages 18-21.
Crossref
Crossref
Frédéric FREZARD & Arlette GARNIER‐SUILLEROT. (2005) Comparison of the membrane transport of anthracycline derivatives in drug‐resistant and drug‐sensitive K562 cells. European Journal of Biochemistry 196:2, pages 483-491.
Crossref
Crossref
Ellen C. Spoelstra, Henk Dekker, Gerrit Jan Schuurhuis, Henricus J. Broxterman & Jan Lankelma. (1991) P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Biochemical Pharmacology 41:3, pages 349-359.
Crossref
Crossref
Erland J.F. Demant, Maxwell Sehested & Peter Buhl Jensen. (1990) A model for computer simulation of P-glycoprotein and transmembrane ΔpH-mediated anthracycline transport in multidrug-resistant tumor cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1055:2, pages 117-125.
Crossref
Crossref
Jolanta Tarasiuk, Frédéric Frézard, Arlette Garnier-Suillerot & Liliane Gattegno. (1989) Anthracycline incorporation in human lymphocytes. Kinetics of uptake and nuclear concentration. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1013:2, pages 109-117.
Crossref
Crossref
Edward J. Osborne & William J. MacKillop. (1987) The effect of exposure to elevated temperatures on membrane permeability to Adriamycin in Chinese hamster ovary cells in vitro. Cancer Letters 37:2, pages 213-224.
Crossref
Crossref
Romano Danesi, Mario del Tacca, Carla Bernardini & Sergio Penco. (1987) Exogenous doxorubicinol induces cardiotoxic effects in rats. European Journal of Cancer and Clinical Oncology 23:7, pages 907-913.
Crossref
Crossref
D.J. KERR, T.E. WHELDON, A.M. KERR & S.B. KAYE. (1987)
In Vitro
Chemosensitivity Testing Using the Multicellular Tumor Spheroid Model
. Cancer Drug Delivery 4:2, pages 63-73.
Crossref
Crossref
David J. Kerr, Anne M. Kerr, R.Ian Freshney & Stanley B. Kaye. (1986) Comparative intracellular uptake of adriamycin and 4'-deoxydoxorubicin by nonsmall cell lung tumor cells in culture and its relationship to cell survival. Biochemical Pharmacology 35:16, pages 2817-2823.
Crossref
Crossref
Karen G. Louie, Thomas C. Hamilton, Margaret A. Winker, Brent C. Behrens, Takashi Tsuruo, Raymond W. KleckerJr.Jr., McKoy, Karen R. Grotzinger, Charles E. Myers, Robert C. Young & Robert F. Ozols. (1986) Adriamycin accumulation and metabolism in adriamycin-sensitive and -resistant human ovarian cancer cell lines. Biochemical Pharmacology 35:3, pages 467-472.
Crossref
Crossref
Diana A. Bates, Henry Fung & William J. Mackillop. (1985) Adriamycin uptake, intracellular binding and cytotoxicity in Chinese hamster ovary cells. Cancer Letters 28:2, pages 213-221.
Crossref
Crossref
Thomas G. Burke & Thomas R. Tritton. (2002) Structural basis of anthracycline selectivity for unilamellar phosphatidylcholine vesicles: an equilibrium binding study. Biochemistry 24:7, pages 1768-1776.
Crossref
Crossref
Jill M. Siegfried, Thomas G. Burke & Thomas R. Tritton. (1985) Cellular transport of anthracyclines by passive diffusion. Biochemical Pharmacology 34:5, pages 593-598.
Crossref
Crossref
Herbert S. Schwartz. 1983. Molecular Aspects of Anti-Cancer Drug Action. Molecular Aspects of Anti-Cancer Drug Action
93
125
.